Mosaic Biosciences
Mosaic: Accelerating protein therapeutic R&D with expert biopharma leadership and synthetic material design.
Founded
2009Mosaic: Accelerating protein therapeutic R&D with expert biopharma leadership and synthetic material design.
Founded with a focus on accelerating protein therapeutic research and development, Mosaic Biosciences is dedicated to transforming concepts into viable drug candidates. The company offers end-to-end discovery capabilities for protein and antibody therapeutics, leveraging a multidisciplinary team of expert scientists and cutting-edge technology. Mosaic's core mission is to provide biopharma leadership and synthetic material design to expedite the R&D process for their partners, aiming to enhance clinical success through rigorous discovery research.
Notable figures affiliated with Mosaic Biosciences include seasoned biopharmaceutical leaders who bring extensive industry experience to the table. The company has achieved significant milestones in the realm of protein and antibody therapeutic discovery, positioning itself as a key player in the biopharma sector. By providing immediate access to data-driven approaches and first-rate technology, Mosaic has made a substantial impact on the efficiency and effectiveness of therapeutic development programs, fostering innovation and accelerating the journey from concept to clinical application.
Companies similar to Mosaic Biosciences include NanoMosaic, Da Yu Protein Sciences, Design Pharmaceuticals and BigHat Biosciences.
Mosaic Biosciences was founded in 2009.
Mosaic Biosciences' headquarters is located in Boulder, CO, US.
Mosaic Biosciences' most recent funding round was for $11.4M (USD) in June 2022.
As of Jun 14, 2022, Mosaic Biosciences has disclosed funding of $14.7M (USD). Undisclosed round amounts are excluded.
Mosaic Biosciences has 39 employees as of Feb 5, 2024.
bighatbio.com
